What We're Reading
Industry reads hand-picked by our editors
Jul 27, 2021
-
CNN
Debate emerges around Covid-19 testing strategies in schools as districts plan to reopen
-
STAT
Epic’s AI algorithms, shielded from scrutiny by a corporate firewall, are delivering inaccurate information on seriously ill patients
-
Kaiser Health News
The Pandemic Made Telemedicine an Instant Hit. Patients and Providers Feel the Growing Pains.
-
TCTMD
3M TAVR: Minimalist TAVI Pathway Saves Money
Jul 26, 2021
-
Wall Street Journal
PerkinElmer Buying Antibodies Maker BioLegend for $5.25 Billion
-
MedCity News
Would Illumina’s acquisition of GRAIL constrict the expansion of the liquid biopsy space?
-
MedPage Today
Surprising Tradeoffs of Valve-in-Valve TAVR vs Redo Surgery
-
Axios
A reality check on the GOP's push for coronavirus antibody testing
Jul 23, 2021
Jul 22, 2021
Jul 21, 2021
Jul 20, 2021
-
NJBIZ
BD acquisition of Velano Vascular adds needle-free blood draw technology
-
TCTMD
Acute MI More Common After TAVI vs SAVR, Real-World Data Suggest
-
MedCity News
After raising $260M, Imperative Care looks to build portfolio of stroke-care companies
-
MedPage Today
Does Post-AVR Afib Risk Merit Months of Vigilance?
